Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
**MT-CYB pseudogene 28 (MTCYBP28)** is classified as a pseudogene derived from the mitochondrially encoded cytochrome b gene. It is located on human chromosome 16 and is not believed to encode a functional protein or to have a biological function similar to the active MT-CYB gene in mitochondrial DNA. As a pseudogene, MTCYBP28 does not function as a receptor, enzyme, transporter, or therapeutic target. There is no evidence supporting any disease associations, drug interactions, or biomarker utility for this locus. Its principal relevance is as a genomic relic or sequence similarity to the functional MT-CYB gene, rather than as an active molecule with physiological or pathological roles[2][4][9][10].\n\n**Key clarifications:**\n- The functional gene MT-CYB encodes cytochrome b, an essential component of mitochondrial complex III, with roles in oxidative phosphorylation and several mitochondrial disorders[1][3][5][7]. This refers to the active mitochondrial gene, not the pseudogene.\n- MTCYBP28 is explicitly annotated as a *pseudogene* in multiple reputable databases and does not encode a protein product[2][4][9][10].\n- As a pseudogene, it is not considered a drug target or molecular entity of therapeutic relevance.\n\n**Errors and limitations:**\n- If queried as a therapeutic target, MTCYBP28 is incorrect. Only the active MT-CYB gene is relevant to mitochondrial biology and disease.\n- There can be confusion between pseudogenes like MTCYBP28 and their functional counterparts, but only the mitochondrial MT-CYB is biologically active.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MT-CYB pseudogene 28 (MTCYBP28).